(Q36013046)

11 August 2017

1 reference

title

Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence (English)

1 reference

cost-effectiveness analysis

11 August 2017

1 reference

Rachel A Elliott

1

1 reference

11 August 2017

Nick Barber

series ordinal

2

1 reference

11 August 2017

Rob Horne

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

18 January 2005

1 reference

Annals of Pharmacotherapy

11 August 2017

1 reference

11 August 2017

39

1 reference

11 August 2017

3

1 reference

11 August 2017

508-515

1 reference

Cost of relapse in schizophrenia

11 August 2017

1 reference

Interventions to enhance patient adherence to medication prescriptions: scientific review.

21 January 2018

1 reference

Should we consider non-compliance a medical error?

21 January 2018

1 reference

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

21 January 2018

1 reference

A critical evaluation of the methodology of the literature on medication compliance.

21 January 2018

1 reference

Clinical interventions for treatment non-adherence in psychosis: meta-analysis

21 January 2018

1 reference

Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program

21 January 2018

1 reference

The cost and effectiveness of an education program for adults who have asthma

21 January 2018

1 reference

A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis

21 January 2018

1 reference

The impact of health education on frequency and cost of health care use by low income children with asthma

21 January 2018

1 reference

Cost-benefit analysis of psychosomatic therapy in asthma

21 January 2018

1 reference

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

21 January 2018

1 reference

Cost-effectiveness evaluation of compliance therapy for people with psychosis.

21 January 2018

1 reference

Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications

21 January 2018

1 reference

Cost-effectiveness of a worksite hypertension treatment program.

21 January 2018

1 reference

Multiple-family groups and psychoeducation in the treatment of schizophrenia.

21 January 2018

1 reference

Economic analysis of two structured treatment and teaching programs on asthma.

21 January 2018

1 reference

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants

21 January 2018

1 reference

Cost-effectiveness of a collaborative care program for primary care patients with persistent depression

21 January 2018

1 reference

Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression.

21 January 2018

1 reference

A Telecommunications System for Monitoring and Counseling Patients With Hypertension Impact on Medication Adherence and Blood Pressure Control

21 January 2018

1 reference

Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions

21 January 2018

1 reference

Long-term (3-year) economic evaluation of intensive patient education for self-management during the first year in new asthmatics.

21 January 2018

1 reference

Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care

21 January 2018

1 reference

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

Costs of illness in cost-effectiveness analysis. A review of the methodology

21 January 2018

1 reference

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap

21 January 2018

1 reference

The distribution of health care costs and their statistical analysis for economic evaluation

21 January 2018

1 reference

Measurement, correlates, and health outcomes of medication adherence among seniors

21 January 2018

1 reference

Ability to pay and the decision to medicate

21 January 2018

1 reference

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

21 January 2018

1 reference

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

21 January 2018

1 reference

Prescription Use Behavior Among Medicare Beneficiaries with Capped Prescription Benefits

21 January 2018

1 reference

Access to medicines: cost as an influence on the views and behaviour of patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E398

1 reference

11 August 2017

1 reference